vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
Lifeway Foods, Inc. is the larger business by last-quarter revenue ($55.4M vs $32.6M, roughly 1.7× RxSight, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -28.1%, a 32.7% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs -18.9%). RxSight, Inc. produced more free cash flow last quarter ($-2.3M vs $-17.4M). Over the past eight quarters, Lifeway Foods, Inc.'s revenue compounded faster (11.4% CAGR vs 5.1%).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
LWAY vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $32.6M |
| Net Profit | $2.5M | $-9.2M |
| Gross Margin | 27.8% | 77.5% |
| Operating Margin | 6.8% | -34.8% |
| Net Margin | 4.6% | -28.1% |
| Revenue YoY | 18.0% | -18.9% |
| Net Profit YoY | 1688.1% | -54.1% |
| EPS (diluted) | $0.15 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $32.6M | ||
| Q3 25 | $57.1M | $30.3M | ||
| Q2 25 | $53.9M | $33.6M | ||
| Q1 25 | $46.1M | $37.9M | ||
| Q4 24 | $46.9M | $40.2M | ||
| Q3 24 | $46.1M | $35.3M | ||
| Q2 24 | $49.2M | $34.9M | ||
| Q1 24 | $44.6M | $29.5M |
| Q4 25 | $2.5M | $-9.2M | ||
| Q3 25 | $3.5M | $-9.8M | ||
| Q2 25 | $4.2M | $-11.8M | ||
| Q1 25 | $3.5M | $-8.2M | ||
| Q4 24 | $-160.0K | $-5.9M | ||
| Q3 24 | $3.0M | $-6.3M | ||
| Q2 24 | $3.8M | $-6.1M | ||
| Q1 24 | $2.4M | $-9.1M |
| Q4 25 | 27.8% | 77.5% | ||
| Q3 25 | 28.7% | 79.9% | ||
| Q2 25 | 28.6% | 74.9% | ||
| Q1 25 | 23.9% | 74.8% | ||
| Q4 24 | 25.3% | 71.6% | ||
| Q3 24 | 25.7% | 71.4% | ||
| Q2 24 | 27.0% | 69.5% | ||
| Q1 24 | 25.8% | 70.1% |
| Q4 25 | 6.8% | -34.8% | ||
| Q3 25 | 8.8% | -40.1% | ||
| Q2 25 | 10.8% | -41.6% | ||
| Q1 25 | 3.4% | -28.2% | ||
| Q4 24 | 1.5% | -21.5% | ||
| Q3 24 | 9.1% | -26.1% | ||
| Q2 24 | 11.0% | -23.9% | ||
| Q1 24 | 8.0% | -36.2% |
| Q4 25 | 4.6% | -28.1% | ||
| Q3 25 | 6.2% | -32.4% | ||
| Q2 25 | 7.9% | -35.0% | ||
| Q1 25 | 7.7% | -21.6% | ||
| Q4 24 | -0.3% | -14.8% | ||
| Q3 24 | 6.5% | -17.9% | ||
| Q2 24 | 7.7% | -17.4% | ||
| Q1 24 | 5.4% | -30.8% |
| Q4 25 | $0.15 | $-0.22 | ||
| Q3 25 | $0.23 | $-0.24 | ||
| Q2 25 | $0.28 | $-0.29 | ||
| Q1 25 | $0.23 | $-0.20 | ||
| Q4 24 | $0.00 | $-0.14 | ||
| Q3 24 | $0.19 | $-0.16 | ||
| Q2 24 | $0.25 | $-0.16 | ||
| Q1 24 | $0.16 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $85.8M | $275.7M |
| Total Assets | $105.6M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $228.1M | ||
| Q3 25 | $23.0M | $227.5M | ||
| Q2 25 | $21.2M | $227.5M | ||
| Q1 25 | $19.4M | $229.3M | ||
| Q4 24 | $16.7M | $237.2M | ||
| Q3 24 | $20.6M | $237.1M | ||
| Q2 24 | $14.6M | $233.3M | ||
| Q1 24 | $12.0M | $125.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $85.8M | $275.7M | ||
| Q3 25 | $82.8M | $276.0M | ||
| Q2 25 | $78.7M | $278.0M | ||
| Q1 25 | $74.2M | $279.3M | ||
| Q4 24 | $71.9M | $281.2M | ||
| Q3 24 | $71.5M | $277.3M | ||
| Q2 24 | $68.0M | $275.2M | ||
| Q1 24 | $63.5M | $163.9M |
| Q4 25 | $105.6M | $311.8M | ||
| Q3 25 | $109.5M | $308.5M | ||
| Q2 25 | $98.3M | $309.0M | ||
| Q1 25 | $93.7M | $313.0M | ||
| Q4 24 | $90.5M | $318.6M | ||
| Q3 24 | $91.3M | $310.5M | ||
| Q2 24 | $84.9M | $305.5M | ||
| Q1 24 | $82.8M | $183.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | $-1.1M |
| Free Cash FlowOCF − Capex | $-17.4M | $-2.3M |
| FCF MarginFCF / Revenue | -31.5% | -6.9% |
| Capex IntensityCapex / Revenue | 31.9% | 3.5% |
| Cash ConversionOCF / Net Profit | 0.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0K | $-1.1M | ||
| Q3 25 | $6.9M | $-1.2M | ||
| Q2 25 | $3.9M | $-4.4M | ||
| Q1 25 | $-150.0K | $-8.8M | ||
| Q4 24 | $-2.6M | $-4.3M | ||
| Q3 24 | $7.5M | $650.0K | ||
| Q2 24 | $6.5M | $-4.0M | ||
| Q1 24 | $1.5M | $-9.3M |
| Q4 25 | $-17.4M | $-2.3M | ||
| Q3 25 | $1.8M | $-1.8M | ||
| Q2 25 | $1.6M | $-5.9M | ||
| Q1 25 | $-2.4M | $-9.4M | ||
| Q4 24 | $-3.8M | $-5.1M | ||
| Q3 24 | $5.9M | $-453.0K | ||
| Q2 24 | $5.1M | $-5.5M | ||
| Q1 24 | $-923.0K | $-11.3M |
| Q4 25 | -31.5% | -6.9% | ||
| Q3 25 | 3.1% | -5.8% | ||
| Q2 25 | 3.0% | -17.6% | ||
| Q1 25 | -5.1% | -24.8% | ||
| Q4 24 | -8.2% | -12.7% | ||
| Q3 24 | 12.8% | -1.3% | ||
| Q2 24 | 10.4% | -15.9% | ||
| Q1 24 | -2.1% | -38.2% |
| Q4 25 | 31.9% | 3.5% | ||
| Q3 25 | 9.0% | 1.9% | ||
| Q2 25 | 4.3% | 4.6% | ||
| Q1 25 | 4.8% | 1.5% | ||
| Q4 24 | 2.7% | 2.1% | ||
| Q3 24 | 3.3% | 3.1% | ||
| Q2 24 | 2.9% | 4.4% | ||
| Q1 24 | 5.5% | 6.7% |
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
